The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
Delivery apps are allowing Chinese citizens to get their hands on the popular weight-loss and diabetes drugs at the touch of ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...
Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...
Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
In the first episode of the The Skinny Jab Revolution presenter Kathryn Thomas looks at the emergence of GLP-1 drugs, such as ...
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...